- VERIFIED ANALYTICAL DATA AVAILABLE
- SECURE INSTITUTIONAL PORTAL
- In-Vitro Laboratory Research Use Only
A proprietary multi-peptide research formulation combining GHK-Cu (Copper Tripeptide-1), BPC-157 (Pentadecapeptide), and TB-500 (Thymosin Beta-4 Fragment). This blend facilitates the study of simultaneous signaling pathway activation in cellular models relevant to extracellular matrix remodeling, vascular signaling, and cytoskeletal dynamics.
The GLOW blend allows researchers to investigate the simultaneous modulation of distinct yet potentially complementary biological pathways.
GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper) is a tripeptide complex with high affinity for copper ions. In research, it is primarily utilized to study extracellular matrix remodeling.
BPC-157 (Body Protection Compound) is a pentadecapeptide investigated for cytoprotective signaling properties. Research focuses on nitric-oxide–associated pathways and growth-factor signaling in fibroblast and endothelial models.
TB-500 is a synthetic fragment of the naturally occurring protein Thymosin Beta-4. Its primary research mechanism involves regulation of actin polymerization and cytoskeletal organization.
Reduction of myofibroblast differentiation (anti-fibrotic signaling context)
The rationale for combining these peptides lies in their non-overlapping mechanisms of action. Research designs often assess whether simultaneous activation of:
produces different tissue-repair–associated cellular dynamics compared to isolated administration. Data on direct molecular interaction between these components in solution remain limited.
Competitive Binding: Competitive receptor or transporter binding has not been fully characterized for this mixture.
